Logo

LAMP

Dx Startup Detect Preparing to Roll Out Next-Gen Molecular Instrument, Broaden Test Menu
Premium

On the heels of its COVID-19 test, the firm is developing a multiplex test for flu/COVID-19 and targeting tests for Streptococcus and STIs.

Anavasi Diagnostics Poised to Debut Rapid POC MDx System, COVID-19 Test
Premium

The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.

Lucira Health Enters Debt Facility of up to $80M

The debt financing, with Hercules Capital and Silicon Valley Bank, will help broaden the firm's commercial activities and bolster its capital reserves.

UK Researchers Develop Low-Cost Molecular COVID-19 Testing in a Backpack
Premium

Based on RT-LAMP and commonly found hardware, the technology shows potential for detecting SARS-CoV-2 and other infectious diseases in low-resource settings.

Cheap, Rapid 'Flurona' Test Developed by UCSB Solves Problems With LAMP Sensitivity
Premium

The team was able to eliminate a key issue with using LAMP for SARS-CoV-2: false positives as a result of too-high sensitivity.

Jan 18, 2022

Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark

Jan 13, 2022

UIC Researchers Using Optimized RT-Lamp Technology for Low-Cost COVID-19 Testing
Premium

Dec 8, 2021

Genedrive Rapid Molecular COVID-19 Test Receives CE Mark

Nov 9, 2021

Anavasi Diagnostics Awarded $14.9M NIH Grant for Rapid Molecular SARS-CoV-2 Test

May 18, 2021

Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test

Apr 26, 2021

Lucira Health SARS-CoV-2 Self-Test Receives Health Canada Conditional Authorization

Apr 12, 2021

Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

Mar 23, 2021

FDA Grants EUAs for Direct-to-Consumer Versions of Color Coronavirus Test, Sample Collection Kit

Mar 18, 2021

Lucira Health Focuses on Consumer-Friendly Approach to Home Infectious Disease Testing
Premium

Mar 18, 2021

MicrosensDx Nabs CE Mark for Rapid SARS-CoV-2 LAMP Test

Feb 5, 2021

At-Home Infectious Disease Test Developer Lucira Health Goes Public at $17 Per Share

Feb 4, 2021

Explosive Detection Device Manufacturer DetectaChem Pivots to SARS-CoV-2 Testing
Premium

Feb 3, 2021

Stanford Team Developing Low-Cost, At-Home, Molecular COVID-19 Saliva Test
Premium

Jan 15, 2021

Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market
Premium

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

Dec 21, 2020

COVID Assays Using CRISPR, Smartphones Show Potential for At-Home Testing
Premium

Dec 18, 2020

GeneMe Commercializing Rapid COVID-19 Tests With Extremely Low Limits of Detection
Premium

Nov 18, 2020

Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx
Premium

Nov 18, 2020

FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health

Nov 4, 2020

FDA Reissues Color Coronavirus Test EUA for Sample Collection Changes

Breaking News
The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.